What the evidence says. Several controlled trials; effects real but modest or context-dependent.
What is Arabinoxylan?
Arabinoxylan (Cereal hemicellulose (AXOS)) is a prebiotic fiber used for lowers post-prandial blood glucose and insulin responses — the basis for an efsa-authorized health claim at ~8 g of wheat-endosperm ax-rich fiber per meal. NutriDex grades the human evidence as Moderate. Arabinoxylan (AX) is the main soluble hemicellulose fiber of cereal grains such as wheat, rye, barley and psyllium; enzymatically shortened forms are called arabinoxylan-oligosaccharides (AXOS). Its best-supported effect is on glucose: a 2025 systematic review and meta-analysis of clinical and preclinical studies found AX significantly reduced postprandial glucose and insulin responses, and the EFSA authorizes a health claim that ~8 g of AX-rich fiber from wheat endosperm per meal lowers post-prandial glycaemia. Small randomized crossover trials in people with type 2 diabetes or impaired glucose tolerance also show lower fasting glucose, HbA1c and triglycerides, and human studies consistently show AXOS is bifidogenic and raises short-chain fatty acids (especially butyrate). Evidence is most robust for acute glycemic and microbiome endpoints; data on LDL cholesterol, weight and long-term clinical outcomes are thinner and less consistent, with trials generally small.
Purported Benefits
✓Lowers post-prandial blood glucose and insulin responses — the basis for an EFSA-authorized health claim at ~8 g of wheat-endosperm AX-rich fiber per meal
✓Improves longer-term glycemic control in type 2 diabetes and impaired glucose tolerance: small crossover RCTs report reduced fasting glucose, HbA1c, fructosamine and apolipoprotein B
✓Reliably bifidogenic — AXOS and AX increase fecal Bifidobacterium and butyrate-producing bacteria, raising short-chain fatty acid (SCFA) production
✓Can modestly lower fasting serum triglycerides in some trials (effect on LDL/total cholesterol is inconsistent and generally not significant)
✓Increases satiety hormones and lowers ghrelin response in some studies, which may support appetite control
✓As a fermentable soluble fiber, contributes to stool bulking and laxation, though dedicated constipation trials are limited
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
Lowers fasting triglyceridesSmall crossover RCTs lowered triglycerides; LDL/total-cholesterol effects inconsistent and generally non-significant.
Preliminary
↑ benefit · small
2
Dosing & Compounds
Typical Dose
For postprandial glucose: ~8 g of wheat-endosperm AX-rich fiber consumed as part of a carbohydrate meal (EFSA condition). Metabolic trials in diabetes/IGT used roughly 6-15 g/day of AX added to bread or muffins over 4-6 weeks. For a bifidogenic/prebiotic effect, AXOS has been effective from ~2.2 g/day up to ~10 g/day; tolerance studies support doses up to about 10 g/day. Best taken with cereal-based meals.
Active Compounds
AXOS ingredients (e.g. NAXUS / Comet Bio, BioActor AXOS) used in functional foods and supplementsWheat-endosperm arabinoxylan concentrates and wheat-bran/aleurone AX-rich fractionsAXOS-enriched (endoxylanase-treated) breads and cereal productsRice-bran arabinoxylan compound (e.g. MGN-3/BioBran, a different immunomodulatory product)Food sources: whole wheat, rye, barley, oats, psyllium husk, wheat and rice bran, and other whole-grain cereals
Safety & Cautions
⚠
Generally well tolerated. Because AX and especially AXOS are fermented in the colon, the main side effects are flatulence, bloating and abdominal discomfort, which are dose-dependent and tend to ease over time; doses around 10 g/day of AXOS are tolerated in healthy adults, with more gas at higher intakes. As fermentable fibers they can aggravate symptoms in some people with IBS or on a low-FODMAP diet (start low and increase gradually with adequate fluids). Like other viscous/bulking fibers, AX may slow or reduce absorption of co-ingested medications and minerals, so separate doses from medications by 2-4 hours. People with celiac disease or wheat allergy should avoid wheat-derived AX/AXOS products. Note that rice-bran arabinoxylan compound (MGN-3/BioBran) is a distinct immunomodulatory product and its claims should not be conflated with cereal AX/AXOS fiber. Those with diabetes on glucose-lowering drugs should monitor blood sugar. Educational only — always check with your doctor or pharmacist before combining Arabinoxylan with any medicine.
Arabinoxylan is most often taken for Lowers post-prandial blood glucose and insulin responses — the basis for an EFSA-authorized health claim at ~8 g of wheat-endosperm AX-rich fiber per meal, Improves longer-term glycemic control in type 2 diabetes and impaired glucose tolerance: small crossover RCTs report reduced fasting glucose, HbA1c, fructosamine and apolipoprotein B, Reliably bifidogenic — AXOS and AX increase fecal Bifidobacterium and butyrate-producing bacteria, raising short-chain fatty acid (SCFA) production, Can modestly lower fasting serum triglycerides in some trials (effect on LDL/total cholesterol is inconsistent and generally not significant). Cereal hemicellulose fiber (and its AXOS oligosaccharides) with EFSA-backed postprandial glucose-lowering and a reliable bifidogenic effect.
Does Arabinoxylan work — what does the evidence say?
Moderate evidence. Several controlled trials; effects real but modest or context-dependent. Arabinoxylan (AX) is the main soluble hemicellulose fiber of cereal grains such as wheat, rye, barley and psyllium; enzymatically shortened forms are called arabinoxylan-oligosaccharides (AXOS). Its best-supported effect is on glucose: a 2025 systematic review and meta-analysis of clinical and preclinical studies found AX significantly reduced postprandial glucose and insulin responses, and the EFSA authorizes a health claim that ~8 g of AX-rich fiber from wheat endosperm per meal lowers post-prandial glycaemia. Small randomized crossover trials in people with type 2 diabetes or impaired glucose tolerance also show lower fasting glucose, HbA1c and triglycerides, and human studies consistently show AXOS is bifidogenic and raises short-chain fatty acids (especially butyrate). Evidence is most robust for acute glycemic and microbiome endpoints; data on LDL cholesterol, weight and long-term clinical outcomes are thinner and less consistent, with trials generally small.
What is the typical dose of Arabinoxylan?
For postprandial glucose: ~8 g of wheat-endosperm AX-rich fiber consumed as part of a carbohydrate meal (EFSA condition). Metabolic trials in diabetes/IGT used roughly 6-15 g/day of AX added to bread or muffins over 4-6 weeks. For a bifidogenic/prebiotic effect, AXOS has been effective from ~2.2 g/day up to ~10 g/day; tolerance studies support doses up to about 10 g/day. Best taken with cereal-based meals.
Is Arabinoxylan safe? Any cautions or side effects?
Generally well tolerated. Because AX and especially AXOS are fermented in the colon, the main side effects are flatulence, bloating and abdominal discomfort, which are dose-dependent and tend to ease over time; doses around 10 g/day of AXOS are tolerated in healthy adults, with more gas at higher intakes. As fermentable fibers they can aggravate symptoms in some people with IBS or on a low-FODMAP diet (start low and increase gradually with adequate fluids). Like other viscous/bulking fibers, AX may slow or reduce absorption of co-ingested medications and minerals, so separate doses from medications by 2-4 hours. People with celiac disease or wheat allergy should avoid wheat-derived AX/AXOS products. Note that rice-bran arabinoxylan compound (MGN-3/BioBran) is a distinct immunomodulatory product and its claims should not be conflated with cereal AX/AXOS fiber. Those with diabetes on glucose-lowering drugs should monitor blood sugar.
How many studies support Arabinoxylan?
NutriDex cites 10 sources for Arabinoxylan, graded "Moderate".
Cite this page
APA
Peh, D. (2026). Arabinoxylan (Cereal hemicellulose (AXOS)): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/arabinoxylan
BibTeX
@misc{nutridex_arabinoxylan,
author = {Peh, Daryl},
title = {Arabinoxylan (Cereal hemicellulose (AXOS)): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/arabinoxylan},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.